TY - JOUR
T1 - QoL, CIs, QALYs, and Individualized Rehabilitation
T2 - The Clinical and Practical Benefits of Regularly Assessing the Quality of Life of Adult Cochlear Implant Recipients
AU - Lassaletta, Luis
AU - Calvino, Miryam
AU - Sanchez-Cuadrado, Isabel
AU - Skarzynski, Piotr Henryk
AU - Cywka, Katarzyna B
AU - Czajka, Natalia
AU - Kutyba, Justyna
AU - Tavora-Vieira, Dayse
AU - Van de Heyning, Paul
AU - Mertens, Griet
AU - Staecker, Hinrich
AU - Humphrey, Bryan
AU - Zernotti, Mario
AU - Zernotti, Maximo
AU - Magele, Astrid
AU - Ploder, Marlene
AU - Zabeu, Julia Speranza
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/10/10
Y1 - 2023/10/10
N2 - This study aimed to report quality of life (QoL) scores in unilateral cochlear implant (CI) users and to generate guidance for clinicians on using QoL measures to individualize CI counselling and rehabilitation and to increase access to CIs as a mode of rehabilitation. Participants (n = 101) were unilateral CI users with single-sided deafness (SSD; n = 17), asymmetrical hearing loss (AHL; n = 26), or bilateral hearing loss (Uni; n = 58). Generic QoL was assessed via the Health Utilities Index (HUI-3), and disease-specific QoL was assessed via the Speech, Spatial, and Qualities of Hearing scale (SSQ12) and Nijmegen CI Questionnaire (NCIQ) at preimplantation and at 6 and 12 months of CI use. All groups had significantly increased HUI-3 scores at both intervals. The SSD group showed significant benefit on the SSQ12 at visit 3, the AHL group showed significant benefit on the SSQ12 and most NCIQ subdomains at both intervals, and the Uni group showed significant benefit with both tests at both intervals. Unilateral CI recipients demonstrate improved QoL within the first 12 months of device use. Regular assessment with generic and disease-specific questionnaires has the potential to play an important role in personalizing treatment and possibly in increasing access to CI provision.
AB - This study aimed to report quality of life (QoL) scores in unilateral cochlear implant (CI) users and to generate guidance for clinicians on using QoL measures to individualize CI counselling and rehabilitation and to increase access to CIs as a mode of rehabilitation. Participants (n = 101) were unilateral CI users with single-sided deafness (SSD; n = 17), asymmetrical hearing loss (AHL; n = 26), or bilateral hearing loss (Uni; n = 58). Generic QoL was assessed via the Health Utilities Index (HUI-3), and disease-specific QoL was assessed via the Speech, Spatial, and Qualities of Hearing scale (SSQ12) and Nijmegen CI Questionnaire (NCIQ) at preimplantation and at 6 and 12 months of CI use. All groups had significantly increased HUI-3 scores at both intervals. The SSD group showed significant benefit on the SSQ12 at visit 3, the AHL group showed significant benefit on the SSQ12 and most NCIQ subdomains at both intervals, and the Uni group showed significant benefit with both tests at both intervals. Unilateral CI recipients demonstrate improved QoL within the first 12 months of device use. Regular assessment with generic and disease-specific questionnaires has the potential to play an important role in personalizing treatment and possibly in increasing access to CI provision.
KW - Humans
KW - Adult
KW - Cochlear Implants
KW - Quality of Life
KW - Deafness/rehabilitation
KW - Quality-Adjusted Life Years
KW - Speech Perception
KW - Treatment Outcome
UR - http://www.scopus.com/inward/record.url?scp=85175032414&partnerID=8YFLogxK
U2 - 10.3390/ijerph20206906
DO - 10.3390/ijerph20206906
M3 - Journal article
C2 - 37887644
SN - 1661-7827
VL - 20
JO - International Journal of Environmental Research and Public Health
JF - International Journal of Environmental Research and Public Health
IS - 20
M1 - 6906
ER -